ÂÜÀòÂÒÂ×

Pamela Nelson has extensive experience in the field of regulatory affairs. Pamela is currently the Executive Vice President of Regulatory Affairs at Anagram Therapeutics, Inc., a position they have held since April 2023. Prior to that, they worked as the Senior Vice President of Regulatory Affairs for Lyra Therapeutics from August 2020 to April 2023. From February 2020 to August 2020, they served as the Vice President of Regulatory Affairs for Glaukos Corporation, where they focused on corneal health. Pamela also held the role of Vice President of Regulatory Affairs at Glaukos Corporation from January 2011 to February 2020.

Before joining Glaukos Corporation, Pamela worked as a Regulatory Affairs Consultant for Alnara Pharmaceuticals, Inc. from 2009 to 2011. Pamela also served as the Director of Regulatory Affairs at Altus Pharmaceuticals from 2006 to 2009. Their earlier career includes roles at Alkermes, where they were an Associate Director of Regulatory Affairs from 2002 to 2006, Manager of Regulatory Affairs from 2000 to 2002, and Senior Regulatory Affairs Associate from 1998 to 2000. Pamela began their career in regulatory affairs at Genzyme in 1995. Overall, Pamela Nelson's work experience demonstrates a strong background and expertise in regulatory affairs within the pharmaceutical industry.

Pamela Nelson earned their BA degree from the University of Massachusetts Amherst in 1991. Following that, they went on to complete their M.Ed degree from the same university in 1994.